|
INPPL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.382860E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.32169999999643E-05 |
| Normal-vs-Stage2 |
7.417600E-01 |
| Normal-vs-Stage3 |
1.848800E-01 |
| Normal-vs-Stage4 |
1.199860E-02 |
| Stage1-vs-Stage2 |
6.022100E-03 |
| Stage1-vs-Stage3 |
2.354200E-01 |
| Stage1-vs-Stage4 |
2.402000E-01 |
| Stage2-vs-Stage3 |
2.303600E-01 |
| Stage2-vs-Stage4 |
2.365800E-02 |
| Stage3-vs-Stage4 |
1.339820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.117100E-03 |
| Normal-vs-AfricanAmerican |
2.743100E-03 |
| Normal-vs-Asian |
9.975400E-03 |
| Caucasian-vs-AfricanAmerican |
4.130200E-01 |
| Caucasian-vs-Asian |
5.109000E-01 |
| AfricanAmerican-vs-Asian |
6.719000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.023700E-04 |
| Normal-vs-Female |
1.552370E-01 |
| Male-vs-Female |
2.882200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.754360E-02 |
| Normal-vs-Extreme_Weight |
2.357700E-04 |
| Normal-vs-Obese |
2.364400E-01 |
| Normal-vs-Extreme_Obese |
7.329600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.845800E-01 |
| Normal_Weight-vs-Obese |
3.838200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.746800E-01 |
| Extreme_Weight-vs-Obese |
7.255800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.454570E-01 |
| Obese-vs-Extreme_Obese |
7.075000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.583000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.158900E-03 |
| Normal-vs-Age(61-80Yrs) |
6.416300E-04 |
| Normal-vs-Age(81-100Yrs) |
4.423800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.673590E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.704700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.417900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.034200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.546800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.993800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.944200E-03 |
| Normal-VS-Type2 PRCC |
4.35340000000117E-05 |
| Normal-VS-KIRP CIMP |
3.867800E-01 |
| Normal-VS-Unclassified PRCC |
1.606250E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.017900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.761570E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.482800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.867600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.850300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.140600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.096750E-03 |
| Normal-vs-N1 |
6.483600E-01 |
| Normal-vs-N2 |
3.181000E-01 |
| N0-vs-N1 |
2.374400E-01 |
| N0-vs-N2 |
6.824800E-01 |
| N1-vs-N2 |
4.490400E-01 |
|
|
